{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:40:50Z","timestamp":1760809250441,"version":"build-2065373602"},"reference-count":26,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["160482"],"award-info":[{"award-number":["160482"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,10,9]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There are limited data on the longitudinal impact of Lyme disease. Predictors of recovery have not been fully established using validated data collection instruments. There are sparse data on the immunological response to infection over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This study is a longitudinal cohort study that will recruit 120 participants with Lyme disease in Ontario and Nova Scotia, Canada, with follow-up for up to 24 months. Data will be collected using the Short-Form 36 physical and mental component summaries, Depression and Anxiety Severity Scale Questionnaire, Fatigue Severity Scale and a battery of neuropsychological tests. Mononuclear cells, gene expression and cytokine profiling from blood samples will be used to assess immunological response. Analyses will include the use of non-linear mixed-effects modelling and proportional hazards models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethics approval has been obtained from ethics boards at McMaster University (Hamilton Integrated Research Ethics Board) (7564), Queens University (EMD 315-20) and Nova Scotia Health Research Ethics Board (1027173), and the study is enrolling participants. Written informed consent is obtained from all participants. The results will be disseminated by publication in a peer-reviewed journal and presented at a relevant conference. A brief report will be provided to decision-makers and patient groups.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076833","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T13:31:04Z","timestamp":1698931864000},"page":"e076833","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-5390","authenticated-orcid":false,"given":"Mark","family":"Loeb","sequence":"first","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Brison","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Bramson","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Hatchette","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dalhousie University and the Department of Pathology and Laboratory medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Sander","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Stringer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"2025101810250313000_13.11.e076833.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212637","article-title":"Detection of municipalities at-risk of Lyme disease using passive surveillance of Ixodes Scapularis as an early signal: A province-specific indicator in Canada","volume":"14","author":"Gasmi","year":"2019","journal-title":"PLoS One"},{"key":"2025101810250313000_13.11.e076833.2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.14745\/ccdr.v40i05a01","article-title":"Environmental risk from Lyme disease in central and Eastern Canada: a summary of recent surveillance information","volume":"40","author":"Ogden","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"2025101810250313000_13.11.e076833.3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ttbdis.2016.09.006","article-title":"Analysis of the human population bitten by Ixodes Scapularis ticks in Quebec, Canada: increasing risk of Lyme disease","volume":"7","author":"Gasmi","year":"2016","journal-title":"Ticks Tick Borne Dis"},{"key":"2025101810250313000_13.11.e076833.4","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201611010"},{"key":"2025101810250313000_13.11.e076833.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2015.08.004"},{"key":"2025101810250313000_13.11.e076833.6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10096-018-3417-1","article-title":"Clinical spectrum of Lyme disease","volume":"38","author":"Cardenas-de la Garza","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025101810250313000_13.11.e076833.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.035"},{"key":"2025101810250313000_13.11.e076833.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.02.004"},{"key":"2025101810250313000_13.11.e076833.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2013.09.002"},{"key":"2025101810250313000_13.11.e076833.10","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy078"},{"key":"2025101810250313000_13.11.e076833.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.11.039"},{"key":"2025101810250313000_13.11.e076833.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ277"},{"key":"2025101810250313000_13.11.e076833.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw189"},{"key":"2025101810250313000_13.11.e076833.14","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0126-6"},{"key":"2025101810250313000_13.11.e076833.15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"2025101810250313000_13.11.e076833.16","unstructured":"Ware J , Snow K , Kosinski M , et al . SF-36 Health Survey: Manual and Interpretation Guide. Boston: Health Institute, New England Medical Center, 1993."},{"key":"2025101810250313000_13.11.e076833.17","unstructured":"Ware J , Kosinski M , Keller S . SF-36 Physical and Mental Health Summary Scales: A User\u2019s Manual.2nd ed. Boston: Health Institute, New England Medical Center, 1994."},{"key":"2025101810250313000_13.11.e076833.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.01.008"},{"key":"2025101810250313000_13.11.e076833.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-8-199410150-00002"},{"key":"2025101810250313000_13.11.e076833.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-12-199912210-00003"},{"key":"2025101810250313000_13.11.e076833.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040399","article-title":"Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study","volume":"11","author":"Rebman","year":"2021","journal-title":"BMJ Open"},{"key":"2025101810250313000_13.11.e076833.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01634","article-title":"Robust B cell responses predict rapid resolution of Lyme disease","volume":"9","author":"Blum","year":"2018","journal-title":"Front Immunol"},{"key":"2025101810250313000_13.11.e076833.23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00047-20","article-title":"Global Transcriptome analysis identifies a diagnostic signature for early disseminated Lyme disease and its resolution","volume":"11","author":"Petzke","year":"2020","journal-title":"mBio"},{"key":"2025101810250313000_13.11.e076833.24","doi-asserted-by":"crossref","first-page":"e00100","DOI":"10.1128\/mBio.00100-16","article-title":"Longitudinal Transcriptome analysis reveals a sustained differential gene expression signature in patients treated for acute Lyme disease","volume":"7","author":"Bouquet","year":"2016","journal-title":"mBio"},{"key":"2025101810250313000_13.11.e076833.25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636289","article-title":"Predicting Lyme disease from patients' peripheral blood mononuclear cells Profiled with RNA-sequencing","volume":"12","author":"Clarke","year":"2021","journal-title":"Front Immunol"},{"key":"2025101810250313000_13.11.e076833.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093243","article-title":"Serum inflammatory mediators as markers of human Lyme disease activity","volume":"9","author":"Soloski","year":"2014","journal-title":"PLoS One"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:25:13Z","timestamp":1760808313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,2]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjopen-2023-076833"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076833","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}